Orchestra BioMed Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	42.01	22.26	30.56	19.78	9.94	20.34
Short-Term Investments	53.81	44.55	57.04	64	0.96	15.45
Cash & Short-Term Investments	95.82	66.81	87.6	83.79	10.9	35.79
Cash Growth	43.17%	-23.73%	4.55%	668.95%	-69.56%	-
Receivables	0.05	0.09	0.1	0.1	0.12	0.17
Inventory	0.37	0.17	0.15	0.28	0.07	0.07
Prepaid Expenses	1.53	2.09	1.27	0.53	0.23	0.23
Total Current Assets	97.77	69.17	89.11	84.69	11.32	36.25
Property, Plant & Equipment	3.25	3.49	2.83	3.68	1.12	1.03
Long-Term Investments	2.5	2.5	2.5	2.5	0.4	0.19
Long-Term Deferred Charges	-	-	-	4	0.1	-
Other Long-Term Assets	1.3	1.02	0.77	0.71	0.59	0.63
Total Assets	104.81	76.17	95.21	95.57	13.53	38.09
Accounts Payable	8.47	5.13	2.9	3.97	2.03	1.77
Accrued Expenses	6.84	6.08	5.15	5.38	1.89	1.41
Current Portion of Long-Term Debt	-	-	-	-	2	4
Current Portion of Leases	0.7	0.55	0.65	0.7	-	-
Current Unearned Revenue	4.65	4.44	2.51	6.44	5.54	5.8
Other Current Liabilities	-	-	-	2.09	0.78	1.38
Total Current Liabilities	20.66	16.21	11.21	18.57	12.24	14.36
Long-Term Debt	14.2	14.29	-	9.49	3.67	5.46
Long-Term Leases	1.14	1.69	1.04	1.68	-	-
Long-Term Unearned Revenue	8.66	10.99	14.92	13.1	16.86	15.12
Other Long-Term Liabilities	16.42	0.04	-	0.2	0.54	0.24
Total Liabilities	61.07	43.22	27.17	43.04	33.31	35.18
Common Stock	0.01	0	0	0	-	-
Additional Paid-In Capital	412.51	342.78	316.9	252.27	94.89	94.57
Retained Earnings	-368.82	-309.88	-248.85	-199.73	-166.13	-143.11
Comprehensive Income & Other	0.05	0.05	-0.01	-0.01	-	-0
Total Common Equity	43.74	32.96	68.04	52.53	-71.23	-48.54
Shareholders' Equity	43.74	32.96	68.04	52.53	-19.78	2.91
Total Liabilities & Equity	104.81	76.17	95.21	95.57	13.53	38.09
Total Debt	16.04	16.53	1.69	11.87	5.67	9.46
Net Cash (Debt)	79.79	50.28	85.91	71.92	5.22	26.33
Net Cash Growth	22.58%	-41.47%	19.46%	1276.89%	-80.17%	-
Net Cash Per Share	1.91	1.37	2.59	4.80	2.47	13.08
Filing Date Shares Outstanding	56.46	38.31	35.78	2.52	2.19	2.01
Total Common Shares Outstanding	56.46	38.19	35.78	2.52	2.19	2.01
Working Capital	77.11	52.96	77.91	66.12	-0.92	21.89
Book Value Per Share	0.77	0.86	1.90	20.83	-32.60	-24.11
Tangible Book Value	43.74	32.96	68.04	52.53	-71.23	-48.54
Tangible Book Value Per Share	0.77	0.86	1.90	20.83	-32.60	-24.11
Machinery	2.98	2.53	2.12	2.08	1.51	1.24
Construction In Progress	-	-	-	-	0.02	0.04
Leasehold Improvements	0.16	0.16	0.2	0.19	0.18	0.17

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q